3D-printed Reconstruction Automated Matching System Predicts Size of Double-lumen Tube: a Prospective Double-blinded Randomized Controlled Trial

Sponsor
Sichuan Cancer Hospital and Research Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05899270
Collaborator
Sichuan Province, Department of Science and Technology (Other)
200
2
4.9

Study Details

Study Description

Brief Summary

Lung isolation techniques are commonly used to facilitate surgical exposure and to provide single-lung ventilation for patients. We have developed an automatic comparison software for 3D reconstruction based on CT data (3DRACS). It reconstructs the trachea and bronchus and compares them with the DLT, predicting the most suitable size and depth of the DLT for lung isolation.The aim of this study was to compare whether the use of 3DRACS to select a DLT size compared to conventional empirical selection methods could improve incidence of DLT intubation success and reduce airway injury.

Condition or Disease Intervention/Treatment Phase
  • Other: 3D reconstruction automatic matching system
  • Other: traditional method for selecting double lumen tube
N/A

Detailed Description

Lung isolation techniques are commonly used to facilitate surgical exposure and to provide single-lung ventilation for patients undergoing various intra-thoracic procedures. Lung isolation is primarily accomplished with a double-lumen tube (DLT) or bronchial blocker. One published study showed that residents with limited experience had a 40% error rate in accurately placing a DLT. The accurate choice of the size of DLT is a prerequisite for good lung isolation.Currently, There is lack of proper objective criteria for selecting size of DLT. DLT size selection is estimated empirically using the patient's height and sex, and studies have shown that the size of DLT according CT images of the chest is more accurate than experience. we have developed an automatic comparison software for 3D reconstruction based on CT data (3DRACS). It reconstructs the trachea and bronchus and compares them with the DLT, predicting the most suitable size and depth of the DLT for lung isolation. The aim of this study was to compare whether the use of 3DRACS to select a DLT size compared to conventional empirical selection methods could improve incidence of DLT intubation success and reduce airway injury.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participates recruited from Sichuan Cancer Hospital will randomized to 3D group and control group in 1:1 ratio via a random number list generated by a computer.Participates recruited from Sichuan Cancer Hospital will randomized to 3D group and control group in 1:1 ratio via a random number list generated by a computer.
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
Two investigators performing intubation of DLT will be blinded to the intervention. All participates and researchers responsible for surgery, bronchoscopy assessment, follow-up, data management and analysis will also be blinded to the grouping.
Primary Purpose:
Treatment
Official Title:
Effect of 3D-printed Reconstruction Automated Matching System in Size Selection of Double-lumen Tube:a Prospective Double-blinded Randomised Controlled Trial
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Mar 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: 3D group

In 3D group, the investigator will intubate using DLT chosen by an automatic comparison software for 3D reconstruction based on CT data (3DRACS).

Other: 3D reconstruction automatic matching system
it is an automatic comparison software for 3D reconstruction based on CT data (3DRACS). It reconstructs the trachea and bronchus and compares them with the DLT, predicting the most suitable size and depth of the DLT for lung isolation.

Placebo Comparator: control group

In control group, the size of DLT is based on patient's sex and weight and the height is used to guide the depth of DLT insertion.

Other: traditional method for selecting double lumen tube
In control group, the size of DLT is based on patient's sex and weight and the height is used to guide the depth of DLT insertion.

Outcome Measures

Primary Outcome Measures

  1. Incidence of correct endobronchial intubation. [after intubation]

    Conventional blindly endobronchial intubation is performed firstly and clinical verification was made by the same anesthesiologist, followed by the supervising anesthesiologist using a FOB to check DLT position and successful intubation was considered if the position was proper.

Secondary Outcome Measures

  1. Time to successful intubation [after intubation]

    after completion of induction, the vocal cords are exposed using visual laryngoscopy and Cormack-Lehane grading is performed. The stopwatch is timed as soon as the cuff of DLT crosses the vocal cords and it stops when (1) intubating anesthesiologist consider the DLT is correctly positioned, (2) after a maximum of three attempts have been made, (3) the intubating anesthesiologist think DLT placed correctly is impossible. Each attempt is defined as returning the bronchial lumen of the DLT to the trachea and then attempting to reinsert it. If the DLT is unsuccessfully placed, the intubation will be performed under FOB guidance by the supervising anesthesiologist. This intubation time of supervising anesthesiologist is also counted as part of the successful intubation time.

  2. Degree of pulmonary atrophy [after surgery begin]

    it is a subjective score of 0-10 by the surgeon, ten mean very perfect, zero represent no pulmonary atrophy at all.

  3. Grading of airway injury [When extubation]

    an anesthesiologist over 10 years of FOB experience will assess tracheal and vocal cord related injuries from DLT intubation. Before DLT is prepared to extubation, FOB will be inserted into the bronchial lumen and the tracheal injury will be observed through the FOB along with DLT extubated. All images from the FOB assessment are saved as a video and it will be viewed are by another blinded endoscopist to assess the injury of vocal cords. The severity of tracheal injury was defined as follows: mild (redness, oedema, one to three speckled haemorrhagic lesions), moderate (over 3 mild lesions or one diffuse haemorrhagic lesion) and severe (more than 2 diffuse haemorrhagic lesions). With regard to the vocal cords, the types of lesions are classified as follows: (1) oedema, swelling of the mucosa; (2) petechiae, small red spots on the mucosa; (3) haematoma, bleeding into the mucosa.

  4. Postoperative sore throat and hoarseness [At 1 hour and 24 hours after extubation]

    sore throat is defined as persistent resting pain in the throat region, and throat pain scores were assessed by VAS score (0: no pain; 10: the most unbearable pain). Hoarseness is defined as a change in the quality of voice noted by the patient.

  5. Oxygenation during one-lung ventilation [Intraoperative(from beginning of one lung ventilation to end),an average of 2 hours]

    it is defined as the area under the curve of the SpO2/FiO2 ratio during OLV. The SpO2 and FiO2 values are automatically collected by the monitor at 30 second intervals and any abnormal data due to equipment or human error will be replaced with the previous correct data.

  6. Account times of using FOB [During surgery (from induction to extubation), an average of 3 hour]

    it was defined that FOB was inserted into the tracheal tube and then withdrawn from the tracheal tube from induction to extubation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Aged between 18 and 75 years.

  2. American Society of Anesthesiologists Physical Status (ASA-PS) I-III.

  3. Planned to receive lung resection surgery during lung isolation techniques by using DLT.

  4. Signed informed written consent.

Exclusion Criteria:

The participant experiences any of the following:

  1. Spinal malformation,

  2. Expected difficult airway

  3. Tracheal stenosis

  4. Tracheal tumor

  5. Bronchial tumor

  6. Distorted airway anatomy

  7. Tumors of the mouth or neck

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Sichuan Cancer Hospital and Research Institute
  • Sichuan Province, Department of Science and Technology

Investigators

  • Principal Investigator: Yihao Zhu, master, department of anesthesiology, sichuan cancer hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yihao Zhu, Clinical Professor, Sichuan Cancer Hospital and Research Institute
ClinicalTrials.gov Identifier:
NCT05899270
Other Study ID Numbers:
  • SCCHEC-02-2022-155
First Posted:
Jun 12, 2023
Last Update Posted:
Jun 12, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 12, 2023